28012 Federal Register / Vol. 87, No. 90 / Tuesday, May 10, 2022 / Notices 

COVID–19 pandemic and rapidly 

evolving COVID–19 vaccine 

development and regulatory processes. 

The Secretary of Health and Human 

Services has determined that COVID–19 

is a Public Health Emergency. A notice 

of this ACIP meeting has also been 

posted on CDC’s ACIP website at: http:// 

www.cdc.gov/vaccines/acip/index.html. 

In addition, CDC has sent notice of this 

ACIP meeting by email to those who 

subscribe to receive email updates about 

ACIP. 

Purpose: The committee is charged 

with advising the Director, CDC, on the 

use of immunizing agents. In addition, 

under 42 U.S.C. 1396s, the committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children program, along 

with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under provisions of the Affordable Care 

Act, section 2713 of the Public Health 

Service Act, immunization 

recommendations of the ACIP that have 

been approved by the CDC Director and 

appear on CDC immunization schedules 

must be covered by applicable health 

plans. 

Matters to be Considered: The agenda 

will include discussions on the use of 

COVID–19 vaccines. A recommendation 

vote(s) is scheduled. Agenda items are 

subject to change as priorities dictate. 

For more information on the meeting 

agenda, visit https://www.cdc.gov/ 

vaccines/acip/meetings/meetingsinfo.html. The meeting will be webcast 

live via the World Wide Web; for more 

information on ACIP, visit the ACIP 

website: https://www.cdc.gov/vaccines/ 

acip/index.html. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 

posted on https://www.regulations.gov. 

Therefore, do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

Written Public Comment: The docket 

will be opened to receive written 

comments on May 10, 2022. Written 

comments must be received on or before 

May 19, 2022. 

Oral Public Comment: This meeting 

will include time for members of the 

public to make an oral comment. Oral 

public comment will occur before any 

scheduled votes, including all votes 

relevant to the ACIP’s Affordable Care 

Act and Vaccines for Children program 

roles. Priority will be given to 

individuals who submit a request to 

make an oral public comment before the 

meeting according to the procedures 

below. 

Procedure for Oral Public Comment: 

All persons interested in making an oral 

public comment at the May 19, 2022, 

ACIP meeting must submit a request at 

https://www.cdc.gov/vaccines/acip/ 

meetings/index.html no later than 11:59 

p.m., EDT, May 17, 2022, according to 

the instructions provided. 

If the number of persons requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

time, CDC will conduct a lottery to 

determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals 

regarding their request to speak by email 

on May 18, 2022. To accommodate the 

significant interest in participation in 

the oral public comment session of 

ACIP meetings, each speaker will be 

limited to 3 minutes, and each speaker 

may speak only once per meeting. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–10130 Filed 5–6–22; 4:15 pm] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Council for the Elimination of 

Tuberculosis 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

of the Advisory Council for the 

Elimination of Tuberculosis (ACET). 

This meeting is open to the public and 

limited to 1,000 audio and web 

conference lines. Members of the public 

are welcome to listen to the meeting by 

accessing the telephone number and 

web access provided in the addresses 

section below. Time will be available for 

public comment (registration required to 

provide oral comment). 

DATES: The meeting will be held on June 

21, 2022, from 10:00 a.m. to 4:30 p.m., 

EDT, and June 22, 2022, from 10:00 a.m. 

to 12:05 p.m., EDT. Written comments 

must be received on or before June 7, 

2022. Registration to make oral 

comments must be submitted by June 

16, 2022. 

ADDRESSES: The telephone access 

number is 1–669–254–5252, Webinar 

ID: 160 137 0413, and the Passcode is 

37403108. The web conference access is 

https://cdc.zoomgov.com/j/ 

1601370413?pwd=

T0pucU1yNENQVUlRNUN

VUVBKbHh2UT09, and the Passcode is 

∧Sm35?s2. The number of available 

audio and web conference lines is 1,000. 

FOR FURTHER INFORMATION CONTACT: 

Marah Condit, MS, Committee 

Management Lead, National Center for 

HIV, Viral Hepatitis, STD, and TB 

Prevention, CDC, 1600 Clifton Road NE, 

Mailstop US8–6, Atlanta, GA 30329– 

4027, Telephone:(404)639–3423; Email: 

nchhstppolicy@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Council advises and 

makes recommendations to the 

Secretary of Health and Human 

Services, the Assistant Secretary for 

Health, and the Director, CDC, regarding 

the elimination of tuberculosis. 

Specifically, the Council makes 

recommendations regarding policies, 

strategies, objectives, and priorities; 

addresses the development and 

application of new technologies; and 

reviews the extent to which progress has 

been made toward eliminating 

tuberculosis. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 90 / Tuesday, May 10, 2022 / Notices 28013 

Matters to be Considered: The agenda 

will include discussions on (1) NIHfunded clinical trials; (2) domestic 

pediatric tuberculosis; (3) immigration 

and tuberculosis; and (4) considerations 

for bringing new tuberculosis drugs to 

market. Agenda items are subject to 

change as priorities dictate. 

Public Participation 

Written Public Comment: Members of 

the public are welcome to submit 

written comments in advance of the 

meeting. Written comments must be 

submitted by emailing nchhstppolicy@

cdc.gov with subject line ‘‘June ACET 

Public Comment Registration’’ by June 

7, 2022. 

Oral Public Comment: Individuals 

who would like to make an oral 

comment during the public comment 

period must register by emailing nchhst

ppolicy@cdc.gov with subject line ‘‘June 

ACET Public Comment Registration’’ by 

June 16, 2022. The public comment 

period is on June 22, 2022, at 11:55 a.m., 

EDT. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–09949 Filed 5–9–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2022–0062] 

Advisory Committee on Immunization 

Practices (ACIP) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting and request 

for comment. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting of the Advisory 

Committee on Immunization Practices 

(ACIP). This meeting is open to the 

public. Time will be available for public 

comment. 

DATES: The meeting will be held on June 

22, 2022, from 10:00 a.m. to 5:00 p.m., 

EDT, and June 23, 2022, from 10:00 a.m. 

to 2:00 p.m., EDT (times subject to 

change). The meeting will be webcast 

live via the World Wide Web. Written 

comments must be received on or before 

June 23, 2022. 

ADDRESSES: You may submit comments 

identified by Docket No. CDC–2022– 

0062 by either of the following methods: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

Mailstop H24–8, Atlanta, Georgia 

30329–4027, Attn: ACIP Meeting. 

Instructions: All submissions received 

must include the Agency name and 

Docket Number. All relevant comments 

received in conformance with the 

https://www.regulations.gov suitability 

policy will be posted without change to 

https://www.regulations.gov, including 

any personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

https://www.regulations.gov. Do not 

submit comments by email; CDC does 

not accept comments by email. Written 

public comments submitted by 72 hours 

prior to the ACIP meeting will be 

provided to ACIP members before the 

meeting. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, Centers for 

Disease Control and Prevention, 

National Center for Immunization and 

Respiratory Diseases, 1600 Clifton Road 

NE, Mailstop H24–8, Atlanta, Georgia 

30329–4027, Telephone: (404) 639– 

8367; Email: ACIP@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The committee is charged 

with advising the Director, CDC, on the 

use of immunizing agents. In addition, 

under 42 U.S.C. 1396s, the committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children (VFC) program, 

along with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under provisions of the Affordable Care 

Act, section 2713 of the Public Health 

Service Act, immunization 

recommendations of the ACIP that have 

been approved by the CDC Director and 

appear on CDC immunization schedules 

must be covered by applicable health 

plans. 

Matters to be considered: The agenda 

will include discussions on influenza 

vaccines; pneumococcal vaccine; 

human papillomavirus vaccine; 

measles, mumps, rubella (MMR) 

vaccine; respiratory syncytial virus 

vaccine; rotavirus vaccine; and 

Chikungunya vaccine. Recommendation 

votes on influenza vaccines, 

pneumococcal vaccine, and MMR 

vaccine are scheduled. No VFC votes are 

scheduled. Agenda items are subject to 

change as priorities dictate. For more 

information on the meeting agenda, visit 

https://www.cdc.gov/vaccines/acip/ 

meetings/index.html. The meeting will 

be webcast live via the World Wide 

Web; for more information on ACIP, 

visit the ACIP website: https:// 

www.cdc.gov/vaccines/acip/index.html. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 

posted on https://www.regulations.gov. 

Therefore, do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

Written Public Comment: The docket 

will be opened to receive written 

comments on May 10, 2022. Written 

comments must be received on or before 

June 23, 2022. 

Oral Public Comment: This meeting 

will include time for members of the 

public to make an oral comment. Oral 

public comment will occur before any 

scheduled votes, including all votes 

relevant to the ACIP’s Affordable Care 

Act and Vaccines for Children program 

roles. Priority will be given to 

individuals who submit a request to 

make an oral public comment before the 

meeting according to the procedures 

below. 

Procedure for Oral Public Comment: 

All persons interested in making an oral 

public comment at the June 22–23, 


lotter on DSK11XQN23PROD with NOTICES1